At 4P-Pharma, our foundation is based on scientific rationale. Delta4 has provided us with this essential foundation for our co-development project, enabling us to start from the mechanism of action in the disease. This approach allows us to more accurately and quickly identify and validate therapeutic targets, making our drug development process more efficient and focused.
Revital RattenbachCEO 4P-Pharma
The Delta4 team members are highly competent in big data network analyses both from the disease side and from the drug product and pharmacology side. Their methodology of marrying one with the other led us to new intellectual property.
Johan HäggbladPhD, Chief Scientific Officer at Calliditas Therapeutics
This innovative methodology has enabled us to identify therapeutic targets that have never been described before for specific indications.
Revital RattenbachCEO 4P-Pharma
Thanks to DELTA4, we have been able to speed up the selection of preclinical models, that will allow us to effectively prove the beneficial effects of those drug candidates.
Revital RattenbachCEO 4P-Pharma
Their reporting is thorough and to the point. We highly recommend Delta4 as an AI partner for drug discovery and development.
Johan HäggbladPhD, Chief Scientific Officer at Calliditas Therapeutics
...allowing us to progress in bringing new drugs to patients suffering from serious, untreated diseases.
Revital RattenbachCEO 4P-Pharma